Intermediate and Low Risk Hodgkin Disease - Pediatric
Back to Oncology/Cancer Clinical Trials Main PageCPMC Cancer Services
| Principal Investigator/Contact Information | Protocol Title | Patient Population | Recruitment Period |
| Principal Investigator: CPMC Oncologists Contact: Catherine Carr 415-600-1369 | A Phase III Group-wide Study of Dose-intensive Response-based Chemotherapy and Radiation Therapy for Children and Adolescents with Newly Diagnosed Intermediate Risk Hodgkin Disease. AHOD0031 | Children and adolescents with newly diagnosed intermediate risk Hodgkin Disease | Open |
| Principal Investigator: CPMC Oncologistsbr Contact: Catherine Carr 415-600-1369 | Phase III Study for the Treatment of Children and Adolescents with Newly Diagnosed Low-Risk Hodgkin Disease. AHOD0431 | Children and adolescents with newly diagnosed Low-Risk Hodgkin Disease | Open |
Updated: 4/22/09
Back to top